OCT in Rare Chorioretinal Diseases
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- Oregon Health and Science University
- Study ID
- NCT02141308
- Status
- Recruiting
Conditions
- Central Serous Chorioretinopathy
- Juxtafoveal Telangiecasia
- Polypoidal Choroidal Vasculopathy
- Retinal Arterial Macroaneurysm
- Retinal Artery Occlusions
Eligibility Criteria
- Sex
- ALL
- Age
- 7 Years - 100 Years
- Healthy Volunteers
- Not accepted
Study Details
This study will evaluate the total blood flow in the retina and choroid (structures in the back of the eye) by Doppler optical coherence tomography (OCT) and OCT angiography. Angiography is mapping of the blood vessels. The purpose of measuring blood flow in the retina and choroid is to 1.) determine if rare diseases in these structures causes a change in blood flow compared to healthy eyes and 2.) find out if areas of changed blood flow line up with areas of damage that appear on conventional testing.
Key Dates
- Start date
- May 31, 2014
- Status verified
- Feb 2024
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Rare Chorioretinal DiseaseUp to 150 patients diagnosed with a rare retinal or choroidal disease will be considered and evaluated for enrollment in this study.
Primary Outcome Measure
Total Retinal and Choroidal Blood Flow [ Time Frame: One year ]
Central Contacts
- Kevin Lathrop503-494-8024
- Denny Romfh, OD503-494-4351
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Casey Eye Institute, Oregon Health & Science University | Portland | Oregon | 97239-3098 | John Campbell, MD, MPH (SUB_INVESTIGATOR) Andreas Lauer, MD (SUB_INVESTIGATOR) Christina Flaxel, MD (SUB_INVESTIGATOR) Michael Klein, MD (SUB_INVESTIGATOR) Steven Bailey, MD (SUB_INVESTIGATOR) Eric Suhler, MD (SUB_INVESTIGATOR) David Huang, MD, PhD (SUB_INVESTIGATOR) |